BackAbbvie Overview

Abbvie Current Assets

Abbvie's current assets is $34B.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$33.67B
↑ 15.06% YoYΔ $4.41B vs prior year quarter

Peer trimmed avg / median

Loading

Abbvie Current Assets History

Loading

Abbvie vs. peers: Current Assets Comparison

Loading

Abbvie Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Abbvie (ABBV) FAQ

As of the most recent data (June 2026), ABBV shows a current assets of $34B. That compares with $29B in the prior-year period — up 15.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ABBV's current assets is now $34B (was $29B) — a 15.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Abbvie is outperforming or lagging.

Tracking ABBV's current assets over time shows whether Abbvie is scaling, shrinking, or reshaping that part of the business. The current reading is $34B That compares with $29B in the prior-year period — up 15.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Abbvie's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $34B) with ownership activity and broader fundamentals.

Abbvie's current assets is $34B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.